PD

Peter Dudek

Board Member at Insamo

Cambridge, Massachusetts

Overview

Work Experience

I

Insamo

  • Board Observer

    2024 - Current

M

Merck

  • President & Managing Partner, MRL Ventures Fund

    2021

  • Partner, MRL Ventures Fund

    2018 - 2021

I

InduPro

  • Board Director

    2022

PT

Photys Therapeutics

  • Board Observer

    2021

TT

Tallac Therapeutics

  • Board Director

    2021

MT

Mozart Therapeutics, Inc

  • Board Director

    2020

AT

Ambagon Therapeutics

  • Board Director

    2020

CT

Caraway Therapeutics, Inc.

  • Board Director

    2021 - 2023

    Acquired by Merck.

CT

Carisma Therapeutics

  • Board Observer

    2018 - 2023

LT

LifeMine Therapeutics

  • Board Observer

    2021 - 2023

Education

Investments

Carisma Therapeutics

Series B

Total Funding: $150M

Mozart Therapeutics

Series A

Total Funding: $55M

Xilio Therapeutics

Series B

Total Funding: $330M

Latest Articles

Medium•Jan. 2022

What is Pega and why you should learn it in 2024?

Talks about Java, Pega and Pegasystems

Relevant Websites